Offer - Urjas Oil for just ₹ 1 X
Ripra is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Acidity. Secondary and off-label uses of Ripra have also been mentioned below.
The right dosage of Ripra depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Ripra also has some side effects, the most common being Diarrhoea. While these are the most often observed Ripra side effects, there are can be others also. These have been listed below. Such side effects of Ripra normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Ripra is Safe for pregnant women and Moderate for women who are breastfeeding. Warnings related to Ripra's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Diarrhea (Loose Motions) must refrain from the use of Ripra since this can cause severe adverse effects. The section on Ripra contraindications lists all such conditions.
Drug reaction of Ripra with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Ripra is not safe while driving, and is is not addictive in nature.
Ripra is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Ripra safe for pregnant women?
Ripra is safe for pregnant women.
Is the use of Ripra safe during breastfeeding?
Ripra may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Ripra, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Ripra.
What is the effect of Ripra on the Kidneys?
There are no side effects of Ripra on the kidneys.
What is the effect of Ripra on the Liver?
Very few cases of side effects of Ripra on the liver have been reported.
What is the effect of Ripra on the Heart?
Using Ripra does not have any harmful effects on the heart.
Ripra should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Ripra unless your doctor advises you to do so -
Is this Ripra habit forming or addictive?
No, there is no any evidence that Ripra is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ripra you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Ripra does not show any kind of adverse effect.
Is it able to treat mental disorders?
There is no benefit of taking Ripra for mental disorders.
Interaction between Food and Ripra
Taking Ripra with food does not harm your health.
Interaction between Alcohol and Ripra
Consuming Ripra with alcohol can have many serious effects on your body.
Ripra is a brand name for rabeprazole. It belongs to a class of medications known as proton pump inhibitors. It is available in the form of a tablet, capsule, and injection. Ripra is used to alleviate the symptoms of gastroesophageal reflux disorder (GERD). GERD is a condition in which acid back-flows from the stomach to the esophagus (the tube which connects the stomach with throat) causing heartburn and injury to the esophagus. Ripra is used to prevent this damage. Ripra is also used to treat conditions like Zollinger Ellison syndrome (excessive acid is produced by the stomach). It is used for the treatment of ulcers (sores in the lining of stomach and intestine) and also used in combination with other antibiotics (such as amoxicillin and clarithromycin) to manage H.pylori infection.
Yes, Ripra may cause gas. It is a common side effect of this drug. If you experience excessive gas formation in the stomach after consuming this drug then inform to doctor right away without further delay.
No, Ripra doesn't cause high blood pressure. High blood pressure can be managed by losing some amount of weight, doing some kind of physical activity on a daily basis, eating a healthy diet, reducing sodium in the diet, limiting the amount of alcohol and caffeine, quitting smoking, and taking less stress. If your blood pressure doesn't get controlled, your doctor might start you on a hypertensive drug ( amlodipine, telmisartan etc). Please follow the instructions of your doctor completely.
Yes, Ripra is safe to take as long as it is prescribed by your doctor. However, in some people, it may produce some side effects like a headache, diarrhea, constipation, nausea, vomiting, sore throat and gas. If you suffer from any side effects, please inform your doctor immediately.
Yes, Ripra use is associated with the development of diarrhea. This might be related to an infection caused by Clostridium difficile. If you experience severe diarrhea after consuming this medicine, inform the doctor right away without further delay. In addition, one must take a lot of electrolytes and fluids for preventing dehydration. Taking an anti-diarrheal medication may also help.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078